Tabla 3. Características principales de los sujetos y factores cardiometabólicas asociados
< 50 años => 50 años Mujeres Hombres Mujeres Hombres n=2136 n=1167 n=2192 n=1264 Variables sociales Área de residencia
Rural
1087 (72.90)
404 (27.10)
1257 (68.73)
572 (31.27)
Urbano
1049 (57.89)
763 (42.11)
935 (57.47)
692 (42.53)
Nivel educativo
Técnico/ Universitario
334 (68.44)
154 (31.56)
286 (61.90)
176 (38.10)
Bachiller
524 (67.53)
252 (32.47)
376 (68.61)
172 (31.39)
Ninguno/ Primaria/ Desconocido
1269 (62.54)
760 (37.46)
1528 (62.52)
916 (37.48)
Ingresos mensuales (tertiles)
Bajo (<U$ 175)
756 (67.56)
363 (32.44)
786 (63.54)
451 (36.46)
Medio (U$ 175 - 350)
782 (61.87)
482 (38.13)
678 (61.92)
417 (38.08)
Alto (≥ U$350)
598 (65.00)
322 (35.00)
728 (64.77)
396 (35.23)
Factores modificables de riesgo cardiovascular Ingesta alcohol
No ingesta
1498 (82.53)
317 (17.47)
1624 (82.06)
355 (17.94)
Ingesta alcohol
634 (42.72)
850 (57.28)
567 (38.41)
909 (61.59)
Tabaquismo
No tabaquismo
1750 (72.92)
650 (27.08)
1577 (76.29)
490 (23.71)
< 50 años => 50 años Mujeres Hombres Mujeres Hombres n=2136 n=1167 n=2192 n=1264 Tabaquismo
383 (42.79)
512 (57.21)
609 (44.07)
773 (55.93)
Estado del peso n (%)
Normal
866 (41.5)
595 (52.3)
722 (33.8)
621 (50.1)
Sobrepeso
793 (38.0)
404 (35.5)
905 (42.4)
479 (38.6)
Obesidad
427 (20.5)
140 (12.3)
510 (23.9)
140 (11.3)
Relación cintura/cadera
Tertil 1 (<0.85)
1178 (87.58)
167 (12.42)
884 (88.76)
112 (11.24)
Tertil 2 (0.85 - 0.92)
671 (60.40)
440 (39.60)
826 (71.21)
334 (28.79)
Tertil 3 (≥ 0.92 kg/m2)
270 (32.97)
549 (67.03)
468 (36.62)
810 (63.38)
Actividad física
Alto
232 (60.89)
149 (39.11)
241 (60.10)
160 (39.90)
Moderado
690 (70.91)
283 (29.09)
784 (68.71)
357 (31.29)
Bajo
940 (63.47)
541 (36.53)
883 (60.52)
576 (39.48)
Consumo de frutas y verduras
Nunca
124 (57.94)
90 (42.06)
128 (54.24)
108 (45.76)
Consume frutas o verduras al menos una vez al día
400 (62.40)
241 (37.60)
393 (60.74)
254 (39.26)
Consume frutas y verduras mas de una vez al día
1462 (64.92)
790 (35.92)
1550 (64.64)
254 (39.26)
Factores cardiometabólicas Hipertensión arterial
468 (63.76)
266 (36.24)
1176 (66.33)
597 (33.67)
Diabetes Mellitus 2
87 (66.92)
43 (33.08)
207 (65.92)
107 (34.08)
< 50 años => 50 años Mujeres Hombres Mujeres Hombres n=2136 n=1167 n=2192 n=1264 Enfermedad cardiovascular establecida
89 (74.17)
31 (25.83)
169 (63.77)
96 (36.23)
Tabla 4. Medidas antropométricas
< 50 años =>50 años Mujeres Hombres p Mujeres Hombres p n=2136 n=1167 n=2192 n=1264 Edad (años)
42.4 ± 4.33
42.4 ± 4.20
0.716
58.4 ± 5.68
59.1 ± 5.89
0.001
Variable antropométrica
Altura (cm)
155.6 ± 7.01
167.4± 7.33 <0.001
153.3 ± 6.80
164.8 ± 7.11
<0.001 Peso (kg)
64.4 ±13.53
71.2 ± 12.9
<0.001
64.2 ± 13.24
68.9 ± 13.4
<0.001 Índice masa corporal (kg/m2) IMC 26,5 ± 4.89
25.3 ± 4.01
<0.001
27.2 ± 4.78
25.3 ± 4.09
<0.001 Perímetro cintura (cm)
83.2 ± 11.6
87.1 ± 10.9
<0.001
86.5 ± 11.2
89.2 ± 11.3
<0.001 Perímetro cadera (cm)
98.7 ± 10.1
94.8 ± 9.39
<0.001
99.7 ± 10.3
94.4 ± 9.28
<0.001 Relación cintura/cadera RCC
0.84 ± 0.08
0.91 ± 0.07
<0.001
0.86 ± 0.07
0.94 ± 0.07
<0.001 Relación cintura/cadera por fuerza de empuñadura
0.04 ± 0.01
0.03 ± 0.01
<0.001
0.05 ± 0.02
0.03 ± 0.01
<0.001 Índice fuerza empuñadura
Fuerza empuñadura (kg)
23.2 ± 7.44
36.9 ± 9.8
<0.001
20.8 ± 7.07
31.5 ± 9.2
<0.001 FE/peso (kg)
0.37 ± 0.13
0.52 ± 0.15
<0.001
0.33 ± 0.12
0.47 ± 0.14
<0.001 FE/perímetro cintura (cm)
0.28 ± 0.10
0.42 ± 0.12
<0.001
0.24 ± 0.09
0.36 ± 0.11
<0.001 FE/perímetro cadera (cm)
0.24 ± 0.08
0.39 ± 0.10
<0.001
0.21 ± 0.07
0.34 ± 0.10
<0.001
FE/RCC
27.7 ± 9.07
40.45± 11.22 <0.001
24.2 ± 8.46
33.61± 10.27 <0.001
FE/IMC
0.91 ± 0.32
1.49 ± 0.43
<0.001
0.78 ± 0.29
1.27 ± 0.40
<0.001 Test de t de Student, p<0.05
Tabla 5. Relación de la fuerza de empuñadura en relación con las medidas antropométricas y la presencia de enfermedad cardiovascular.
Fuerza empuñadura (kg) FE/peso (kg) FE/perímetro cintura (cm) FE/perímetro cadera (cm)
FE/RCC
FE/IMC
Hipertensión arterial No
27.18 ± 10.75
0.42 ± 0.16
0.32 ± 0.13
0.28 ± 0.12
31.02 ± 11.82
1.09 ± 0.48
Si
25.77 ± 10.42
0.38 ± 0.15
0.29 ± 0.11
0.26 ± 0.11
28.74 ± 11.35
0.96 ± 0.42
Valor p p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 Diabetes Mellitus tipo 2 No
26.37 ± 10.15
0.41 ± 0.15
0.31 ± 0.12
0.27 ± 0.11
29.96 ± 11.14
1.04 ± 0.44
Si
24.07 ± 9.45
0.35 ± 0.13
0.26 ± 0.11
0.24 ± 0.10
26.39 ± 10.18
0.88 ± 0.38
Valor p p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 Enfermedad cardiovascular establecida No
26.76 ± 10.66
0.41 ± 0.16
0.31 ± 0.12
0.27 ± 0.11
30.31 ± 111.72
1.05 ± 0.46
Si
24.81 ± 10.32
0.37 ± 0.15
0.28 ± 0.12
0.25 ± 0.11
27.80 ± 11.12
0.95 ± 0.43
Valor p p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 Test de t de Student, p<0.05
Tabla 6. Asociación cruda entre obesidad, sarcopenia, obesidad-sarcopénica y presencia de enfermedad cardiovascular
Total Mujeres Hombres Jóvenes Mayores RP IC 95% RP IC 95% RP IC 95% RP IC 95% RP IC 95% Hipertensión arterial PA<90§|<94¶/ FA Q4 Ref.
Ref.
Ref.
Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.24
[1.10- 1.39]
1.15
[0.90- 1.47]
1.32
[1.14- 1.53]
1.09
[0.90- 1.32]
1.14
[0.99- 1.31] PA>=90§|>= 94¶/ FA Q4
1.66
[1.45- 1.91]
1.44
[1.09- 1.91]
1.72
[1.48- 2.11]
1.76
[1.41- 2.22]
1.45
[1.24- 1.69] PA>=90§|>=94¶/FA Q1-Q3
1.92
[1.70- 2.17]
1.79
[1.40- 2.31]
1.99
[1.71- 2.33]
1.64
[1.32- 2.05]
1.57
[1.36- 1.81]
RCC<0.90/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
RCC<0.90/ FA Q1-Q3
1.20
[1.06- 1.37]
1.10
[0.91- 1.33]
1.13
[0.91- 1.39]
1.06
[0.87- 1.31]
1.11
[0.96- 1.29]
RCC>=0.90/ FA Q4
1.19
[1.04- 1.38]
1.14
[0.84- 1.54]
1.26
[1.06- 1.49]
1.15
[0.92- 1.44]
1.10
[0.93- 1.30]
RCC>= 0.90/ FA Q1-Q3
1.56
[1.37- 1.78]
1.45
[1.19- 1.76]
1.58
[1.34- 1.86]
1.25
[0.99- 1.56]
1.24
[1.06- 1.45]
IMC<30†/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.20
[1.10- 1.31]
1.27
[1.03- 1.57]
1.26
[1.12- 1.42]
1.05
[0.88- 1.24]
1.08
[0.98- 1.20]
IMC>=30†/ FA Q4
1.64
[1.39- 1.93]
1.83
[1.37- 2.46]
1.59
[1.33- 1.91]
2.03
[1.54- 2.67]
1.31
[1.10- 1.57]
IMC>=30†/ FA Q1-Q3
1.70
[1.53- 1.89]
1.81
[1.46- 2.27]
1.81
[1.52- 2.15]
1.63
[1.33- 2.02]
1.40
[1.22- 1.59] Diabetes Mellitus 2 PA<90§|<94¶/ FA Q4 Ref.
Ref.
Ref.
Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.47
[1.04- 2.09]
1.57
[0.61- 4.05]
1.52
[1.01- 2.27]
1.04
[0.57- 1.85]
1.47
[0.97- 2.22] PA>=90§|>= 94¶/ FA Q4
2.29
[1.53- 3.42]
3.63
[1.27- 10.4]
2.00
[1.27- 3.14]
2.08
[1.06- 4.04]
2.09
[1.21- 3.63]
Total Mujeres Hombres Jóvenes Mayores RP IC 95% RP IC 95% RP IC 95% RP IC 95% RP IC 95% PA>=90§|>=94¶/FA Q1-Q3
3.41
[2.41- 4.81]
3.45
[1.36- 8.82]
4.22
[2.72- 6.56]
3.10
[1.81- 5.30]
2.78
[1.84- 4.23]
RCC<0.90/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
RCC<0.90/ FA Q1-Q3
1.36
[0.91- 2.04]
1.00
[0.52- 2.07]
1.00
[0.48- 2.11]
1.20
[0.64- 2.23]
1.20
[0.70- 2.06]
RCC>=0.90/ FA Q4
1.48
[0.91- 2.41]
1.75
[0.63- 4.86]
1.69
[0.97- 2.95]
1.44
[0.69- 2.97]
1.32
[0.72- 2.40]
RCC>= 0.90/ FA Q1-Q3
2.86
[1.89- 4.33]
2.17
[1.07- 4.41]
3.21
[1.94- 5.32]
2.49
[1.30- 4.78]
2.17
[1.30- 3.65]
IMC<30†/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.55
[1.12- 2.14]
1.39
[0.61- 3.17]
1.85
[1.30- 2.63]
1.09
[0.65- 1.81]
1.53
[1.07- 2.18]
IMC>=30†/ FA Q4
2.50
[1.62- 3.86]
3.03
[1.07- 8.61]
2.23
[1.35- 3.67]
2.59
[1.36- 4.93]
2.38
[1.30- 4.27]
IMC>=30†/ FA Q1-Q3
2.64
[1.95- 3.57]
2.42
[1.08- 5.47]
3.31
[2.00- 5.49]
3.03
[1.79- 5.09]
2.00
[1.41- 2.84] Enfermedad cardiovascular establecida
PA<90§|<94¶/ FA Q4 Ref.
Ref.
Ref.
Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.65
[1.19- 2.28]
1.40
[0.66- 2.93]
1.88
[1.18- 3.01]
1.66
[0.89- 3.10]
1.61
[1.05- 2.46] PA>=90§|>= 94¶/ FA Q4
1.78
[1.14- 2.79]
1.92
[0.83- 4.46]
1.70
[1.02- 2.86]
1.41
[0.58- 3.37]
2.01
[1.07- 3.80] PA>=90§|>=94¶/FA Q1-Q3
2.45
[1.71- 3.51]
2.03
[0.96- 4.30]
3.08
[1.83- 5.20]
2.89
[1.60- 5.21]
2.14
[1.30- 3.52]
RCC<0.90/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
RCC< 0.90/ FA Q1-Q3
1.35
[0.94- 1.95]
1.17
[0.65- 2.11]
1.41
[0.81- 2.48]
1.26
[0.70- 2.26]
1.67
[0.98- 2.83]
RCC>=0.90/ FA Q4
0.91
[0.58- 1.41]
1.12
[0.44- 2.89]
0.95
[0.57- 1.56]
0.52
[0.23- 1.18]
1.47
[0.79- 2.70]
Total Mujeres Hombres Jóvenes Mayores RP IC 95% RP IC 95% RP IC 95% RP IC 95% RP IC 95%
RCC>=0.90/FA Q1-Q3
1.54
[1.02- 2.33]
1.21
[0.64- 2.27]
1.90
[1.11- 3.25]
1.34
[0.70- 2.59]
1.63
[0.91- 2.96]
IMC<30†/ FA Q4
Ref.
Ref.
Ref.
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.43
[1.10- 1.87]
1.32
[0.70- 2.46]
1.68
[1.14- 2.48]
1.57
[0.94- 2.63]
1.22
[0.89- 1.70]
IMC>=30†/ FA Q4
1.19
[0.69- 2.06]
1.95
[0.81- 4.72]
0.81
[0.39- 1.70]
0.96
[0.31- 2.91]
1.29
[0.64- 2.63]
IMC>=30†/ FA Q1-Q3
1.85
[1.37- 2.51]
1.70
[0.90- 3.20]
2.58
[1.52- 4.38]
2.52
[1.48- 4.29]
1.55
[1.06- 2.67] §Punto de corte de perímetro abdominal para mujeres, ¶Punto de corte de perímetro abdominal para hombres, †kg/m2, PA= perímetro abdominal, RCC= relación cintura cadera, IMC= índice de masa corporal, FA= fuerza de agarre, Q = cuartil *Ajustado
Tabla 7. Análisis multivariado entre obesidad, sarcopenia, obesidad-sarcopénica y presencia de enfermedad cardiovascular
Modelo 1 Modelo 2 RP IC 95% RP IC 95% Valor p Hipertensión arterial PA<90§|<94¶/ FA Q4 Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.24
[1.10-1.39]
1.00
[0.89-1.22]
0.965
PA>=90§|>= 94¶/ FA Q4
1.66
[1.45-1.91]
1.49
[1.31-1.71] <0.001 PA>=90§|>=94¶/FA Q1-Q3
1.92
[1.70-2.17]
1.38
[1.22-1.56] <0.001
RCC<0.90/ FA Q4
Ref.
Ref.
RCC<0.90/ FA Q1-Q3
1.20
[1.06-1.37]
0.94
[0.84-1.09]
0.373
RCC>=0.90/ FA Q4
1.19
[1.04-1.38]
1.14
[0.99-1.32]
0.058
RCC>= 0.90/ FA Q1-Q3
1.56
[1.37-1.78]
1.07
[0.95-1.20]
0.264
IMC<30†/ FA Q4
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.20
[1.10-1.31]
0.97
[0.88-1.06]
0.556
IMC>=30†/ FA Q4
1.64
[1.39-1.93]
1.51
[1.27-1.78] <0.001
IMC>=30†/ FA Q1-Q3
1.70
[1.53-1.89]
1.30
[1.15-1.47] <0.001 Diabetes Mellitus 2 PA<90§|<94¶/ FA Q4 Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.47
[1.04-2.09]
1.21
[0.83-1.76]
0.303
PA>=90§|>= 94¶/ FA Q4
2.29
[1.53-3.42]
1.99
[1.31-2.98] <0.001 PA>=90§|>=94¶/FA Q1-Q3
3.41
[2.41-4.81]
2.55
[1.71-3.78] <0.001
RCC<0.90/ FA Q4
Ref.
Ref.
RCC<0.90/ FA Q1-Q3
1.36
[0.91-2.04]
0.98
[0.65-1.49]
0.945
RCC>=0.90/ FA Q4
1.48
[0.91-2.41]
1.45
[0.91-2.32]
0.114
RCC>= 0.90/ FA Q1-Q3
2.86
[1.89-4.33]
1.93
[1.28-2.92]
0.002
Modelo 1 Modelo 2 RP IC 95% RP IC 95% Valor p
IMC<30†/ FA Q4
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.55
[1.12-2.14]
1.33
[0.95-1.86]
0.090
IMC>=30†/ FA Q4
2.50
[1.62-3.86]
2.35
[1.51-3.66] <0.001
IMC>=30†/ FA Q1-Q3
2.64
[1.95-3.57]
2.15
[1.51-3.06] <0.001 Enfermedad cardiovascular establecida PA<90§|<94¶/ FA Q4 Ref.
Ref.
PA<90§|< 94¶/ FA Q1-Q3
1.65
[1.19-2.28]
1.54
[1.03-2.31]
0.033
PA>=90§|>= 94¶/ FA Q4
1.78
[1.14-2.79]
1.72
[1.05-2.81]
0.030
PA>=90§|>=94¶/FA Q1-Q3
2.45
[1.71-3.51]
2.19
[1.37-3.49]
0.001
RCC<0.90/ FA Q4
Ref.
Ref.
RCC< 0.90/ FA Q1-Q3
1.35
[0.94-1.95]
1.35
[0.87-2.12]
0.182
RCC>=0.90/ FA Q4
0.91
[0.58-1.41]
0.99
[0.61-1.59]
0.960
RCC>=0.90/FA Q1-Q3
1.54
[1.02-2.33]
1.33
[1.83-2.13]
0.234
IMC<30†/ FA Q4
Ref.
Ref.
IMC<30†/ FA Q1-Q3
1.43
[1.10-1.87]
1.31
[0.94-1.88]
0.107
IMC>=30†/ FA Q4
1.19
[0.69-2.06]
1.15
[0.62-2.11]
0.660
IMC>=30†/ FA Q1-Q3
1.85
[1.37-2.51]
1.80
[1.20-2.71]
0.004
Modelo 1: crudo Modelo 2: ajustado por sexo, edad, nivel educativo, antecedente del consumo de tabaco
Figura 1. Asociación de sarcopenia, obesidad y obesidad-sarcopénica con hipertensión arterial.
Mujeres Hombres <50 años >=50 años
Figura 2. Asociación de sarcopenia, obesidad y obesidad-sarcopénica con diabetes mellitus 2.
Mujeres Hombres <50 años >=50 años
Figura 3. Asociación de sarcopenia, obesidad y obesidad-sarcopénica con antecedente de enfermedad cardiovascular.
Mujeres Hombres <50 años >=50 años
Cita: López López, José Patricio (2019), La relación entre obesidad y baja fuerza de agarre u obesidad sarcopénica como predictor de presencia de enfermedad cardiovascular, Universidad Autónoma de Bucaramanga, p. N. http://hdl.handle.net/20.500.12749/1740